| Title | Clinical Lipidology and Metabolic Disorders |
| Abbreviation | Clin. Lipidol. Metab. Disord. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q4); Endocrinology, Diabetes and Metabolism (Q4) |
| h-index | 1 |
| Overall Rank/Ranking | 19734 |
| SCImago Journal Rank (SJR) | 0.189 |
| Impact Score | 0.00 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 26415321 |
| Best Quartile | Q4 |
| Coverage History | 2019 |
Clinical Lipidology and Metabolic Disorders is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q4); Endocrinology, Diabetes and Metabolism (Q4). It is published by Taylor and Francis Ltd.. The overall rank of Clinical Lipidology and Metabolic Disorders is 19734. According to SCImago Journal Rank (SJR), this journal is ranked 0.189. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 1. The best quartile for this journal is Q4.
The ISSN of Clinical Lipidology and Metabolic Disorders journal is 26415321. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Lipidology and Metabolic Disorders is cited by a total of 2 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Clinical Lipidology and Metabolic Disorders is 0.00, which is computed in 2023 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Clinical Lipidology and Metabolic Disorders is 0.00. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2022 | 0.00 |
| 2021 | 0.00 |
| 2020 | 0.00 |
| 2019 | 0.00 |
Clinical Lipidology and Metabolic Disorders has an h-index of 1. It means 1 articles of this journal have more than 1 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical Lipidology and Metabolic Disorders is 26415321. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical Lipidology and Metabolic Disorders is 19734. According to SCImago Journal Rank (SJR), this journal is ranked 0.189. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2022 | 0.189 |
| 2021 | 0.115 |
| 2020 | 0.112 |
| 2019 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2022 | 19734 |
| 2021 | 23758 |
| 2020 | 28179 |
| 2019 | 30595 |
Clinical Lipidology and Metabolic Disorders is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2019. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical Lipidology and Metabolic Disorders is Clin. Lipidol. Metab. Disord.. This abbreviation ('Clin. Lipidol. Metab. Disord.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q4); Endocrinology, Diabetes and Metabolism (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical Lipidology and Metabolic Disorders latest impact IF is 0.00. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.00 (2022) and 0.00 (2022), respectively, in the last 4 years. Moreover, its average IS is 0 in the previous 4 years.
The Clinical Lipidology and Metabolic Disorders has an SJR (SCImago Journal Rank) of 0.189, according to the latest data. It is computed in the year 2023. In the past 4 years, this journal has recorded a range of SJR, with the highest being 0.189 in 2022 and the lowest being in 2019. Furthermore, the average SJR of the Clinical Lipidology and Metabolic Disorders over the previous 4-year period stands at 0.
The latest h-index of the Clinical Lipidology and Metabolic Disorders is 1.
The Clinical Lipidology and Metabolic Disorders is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The Clinical Lipidology and Metabolic Disorders is currently ranked 19734 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 19734 in 2022 and its lowest position of 30595 in 2019.
The standard ISO4 abbreviation for the Clinical Lipidology and Metabolic Disorders is Clin. Lipidol. Metab. Disord..
Clinical Lipidology and Metabolic Disorders is classified as a journal that the Taylor and Francis Ltd. publishes.
The Clinical Lipidology and Metabolic Disorders encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical Lipidology and Metabolic Disorders is assigned the following International Standard Serial Numbers (ISSN): 26415321.
The best quartile for the Clinical Lipidology and Metabolic Disorders is Q4 (2022).
The Clinical Lipidology and Metabolic Disorders coverage history can be summarized as follows: 2019.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| Milan Journal of Mathematics | journal | 5131 | Birkhauser Verlag Basel | 31 | 0.74 |
| Journal of Classical Sociology | journal | 16960 | SAGE Publications Ltd | 31 | 0.68 |
| International Journal of Research and Method in Education | journal | 6367 | Taylor and Francis Ltd. | 41 | 3.31 |
| Indian Phytopathology | journal | 16772 | Springer | 20 | 0.91 |
| Museum Management and Curatorship | journal | 10490 | Routledge | 43 | 2.06 |
| Epigenetics | journal | 4304 | Taylor and Francis Ltd. | 117 | 3.37 |
| Journal of Sociology | journal | 6357 | SAGE Publications Ltd | 66 | 2.82 |
| European Journal of Wildlife Research | journal | 10254 | Springer Verlag | 62 | 1.99 |
| Expert Review of Clinical Pharmacology | journal | 4295 | Taylor and Francis Ltd. | 67 | 3.02 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.00 |
| 2021 | 0.00 |
| 2020 | 0.00 |
| 2019 | 0.00 |
